BELLUS Health Inc. (T.BLU) hit a new 52-week high of $11.62 Monday. BELLUS announced that the 50 mg and 200 mg BID doses of BLU-5937 in its Phase 2b SOOTHE trial for the treatment of RCC achieved statistical significance on the primary endpoint with 34% placebo-adjusted reduction in 24-hour cough frequency observed. BLU-5937 was generally well-tolerated, with low rates of taste-related adverse events reported at all doses.
Altus Group Limited (T.AIF) hit a new 52-week high of $71.14 Monday. No news stories available today
Automotive Properties Real Estate Investment Trust (T.APR.UN) hit a new 52-week high of $13.78 Monday. No news stories available today
NG Energy International Corp. (V.GASX) hit a new 52-week high of $2.00 Monday. No news stories available today
Noront Resources Ltd. (V.NOT) hit a new 52-week high of $1.09 Monday. No news stories available today
Verde Agritech Plc Ordinary Shares (T.NPK) hit a new 52-week high of $2.64 Monday. No news stories available today
VIQ Solutions Inc.(T.VQS) hit a new 52-week high of $37.37 Monday. No news stories available today
Tricon Residential Inc. (T.TCN) hit a new 52-week high of $18.79 Monday. No news stories available today
